SCHEMBL31529217

SCHEMBL31529217

C[C@@H]1O[C@H](Nc2nccc3[nH]cnc23)[C@H](O)[C@H](O)[C@H]1N=[N+]=[N-]

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PAX8 Q06710 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31529297 0.77 PAX8 (0.49) PAX8
SCHEMBL31529122 0.74 IRAK4 (0.42) —
SCHEMBL31529142 0.73 PAX8 (0.47) PAX8
SCHEMBL31529112 0.72 KDM4E (0.30) —
SCHEMBL31529251 0.72 SMN1; SMN2 (0.33) —
SCHEMBL31529228 0.67 PAX8 (0.39) PAX8
SCHEMBL31529201 0.65 NPC1 (0.47) —
SCHEMBL11652097 0.63 PAX8 (0.37) PAX8
SCHEMBL11652071 0.63 PAX8 (0.37) PAX8
SCHEMBL19706509 0.62 EGLN1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090774-A1 CHEMOTHERAPEUTIC COMPOUNDS AND METHODS OF USE SEAGEN INC. (US) 2025-05-01 — — WO disclosed
Send feedback